 Blueprint Medicines NASDAQ:BPMC and Menlo Therapeutics NASDAQ:MNLO are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, valuation and risk. Risk and Volatility Blueprint Medicines has a beta of 1.31, indicating that its stock price is ... 